To strengthen the genuineness of the results, validated by adopting CGGA data, multivariate COX regression analyses have also delineated SLC3A2 alongside other clinicopathological indicators as salient prognostic constituents within glioma. This evidence concerns the gene SLC3A2 and central nervous system cancer.